Advanced search
Add to list

Description of the ICTI consortium : an integrated approach to the study of Chlamydia trachomatis infection

(2006) DRUGS OF TODAY. 42(suppl. A). p.107-114
Author
Organization
Keywords
GENITAL-TRACT INFECTION, PELVIC-INFLAMMATORY-DISEASE, FRAGMENT LENGTH POLYMORPHISM, COST-EFFECTIVENESS, CLINICAL-MANIFESTATIONS, OCULOGENITAL SEROVARS, SUBFERTILE WOMEN, ANTIBODY TESTS, SEX PARTNERS, FOLLOW-UP

Citation

Please use this url to cite or link to this publication:

MLA
Morré, SA, J Spaargaren, JM Ossewaarde, et al. “Description of the ICTI Consortium : an Integrated Approach to the Study of Chlamydia Trachomatis Infection.” DRUGS OF TODAY 42.suppl. A (2006): 107–114. Print.
APA
Morré, SA, Spaargaren, J., Ossewaarde, J., Land, J., Bax, C., Dörr, P., Oostvogel, P., et al. (2006). Description of the ICTI consortium : an integrated approach to the study of Chlamydia trachomatis infection. DRUGS OF TODAY, 42(suppl. A), 107–114. Presented at the Symposium on Chlamydiae and Chlamydial Infections.
Chicago author-date
Morré, SA, J Spaargaren, JM Ossewaarde, JA Land, CJ Bax, PJ Dörr, PM Oostvogel, et al. 2006. “Description of the ICTI Consortium : an Integrated Approach to the Study of Chlamydia Trachomatis Infection.” Drugs of Today 42 (suppl. A): 107–114.
Chicago author-date (all authors)
Morré, SA, J Spaargaren, JM Ossewaarde, JA Land, CJ Bax, PJ Dörr, PM Oostvogel, Daisy Vanrompay, PHM Savelkoul, Y Pannekoek, JEAM van Bergen, HSA Fennema, HJ de Vries, JBA Crusius, AS Pena, JI Ito, and JM Lyons. 2006. “Description of the ICTI Consortium : an Integrated Approach to the Study of Chlamydia Trachomatis Infection.” Drugs of Today 42 (suppl. A): 107–114.
Vancouver
1.
Morré S, Spaargaren J, Ossewaarde J, Land J, Bax C, Dörr P, et al. Description of the ICTI consortium : an integrated approach to the study of Chlamydia trachomatis infection. DRUGS OF TODAY. 2006;42(suppl. A):107–14.
IEEE
[1]
S. Morré et al., “Description of the ICTI consortium : an integrated approach to the study of Chlamydia trachomatis infection,” DRUGS OF TODAY, vol. 42, no. suppl. A, pp. 107–114, 2006.
@article{413022,
  author       = {Morré, SA and Spaargaren, J and Ossewaarde, JM and Land, JA and Bax, CJ and Dörr, PJ and Oostvogel, PM and Vanrompay, Daisy and Savelkoul, PHM and Pannekoek, Y and van Bergen, JEAM and Fennema, HSA and de Vries, HJ and Crusius, JBA and Pena, AS and Ito, JI and Lyons, JM},
  issn         = {1699-3993},
  journal      = {DRUGS OF TODAY},
  keywords     = {GENITAL-TRACT INFECTION,PELVIC-INFLAMMATORY-DISEASE,FRAGMENT LENGTH POLYMORPHISM,COST-EFFECTIVENESS,CLINICAL-MANIFESTATIONS,OCULOGENITAL SEROVARS,SUBFERTILE WOMEN,ANTIBODY TESTS,SEX PARTNERS,FOLLOW-UP},
  language     = {eng},
  location     = {Amsterdam, The Netherlands},
  number       = {suppl. A},
  pages        = {107--114},
  title        = {Description of the ICTI consortium : an integrated approach to the study of Chlamydia trachomatis infection},
  volume       = {42},
  year         = {2006},
}

Web of Science
Times cited: